ãã£ãµãªã³ã»ãŠãã
ARKã€ã³ãã¹ãã¡ã³ãã»ãããžã¡ã³ã, LLC
ããã£ã·ãŒãã®æç§°ã§ç¥ããããã£ãµãªã³ã»ãŠããã¯ãæãè°è«ãåŒã¶ãã¡ã³ããããŒãžã£ãŒã®äžäººã§ããããã¹ã©ãNVIDIAããããã³ã€ã³ã«å¯Ÿããç±çãªé·æåŒ·æ°æŽŸã§ãã2020幎ã«ã¯ãåœŒå¥³ã®æèŠãã¡ã³ãARKKã170%ã®ãªã¿ãŒã³ãèšé²ãã圌女ã®4ã€ã®ãã¡ã³ãã幎éããã©ãŒãã³ã¹ã®ããã10ã«ã©ã³ã¯ã€ã³ããŸããã
ã»ã¯ã¿ãŒå¥é å
ã¬ãã«3ã»ã¯ã¿ãŒå¥å
èš³î®
ã¬ãã«1ã»ã¯ã¿ãŒå¥å
èš³
ã¬ãã«2ã»ã¯ã¿ãŒå¥å
èš³
ã¬ãã«3ã»ã¯ã¿ãŒå¥å
èš³
ãœãããŠã§ã¢ & ITãµãŒãã¹
åå°äœ & åå°äœè£œé è£
眮
ãã€ãªãã¯ãããžãŒ & å»çç ç©¶
éèãã¯ãããžãŒ(Fintech) & ã€ã³ãã©
èªåè» & èªåè»éšå
å»çæ©åš & åå
黿°éä¿¡ãµãŒãã¹
èªç©ºå®å® & é²è¡
å»è¬å
æ©æ¢°ãå·¥å
·ã倧åè»äž¡ãéé & è¹è¶
ç·åå°å£²
ä»ã®
ä¿æéæ
2026Q2î®
2026Q2
2026Q1
2025Q4
2025Q3
2025Q2
2025Q1
çªå·
販売åç§°
ããŒããã©ãªãªã®ãŠã§ã€ã
ååŒæ ªåŒæ°
æäŸ¡ïŒæ¥ä»ïŒ
æäŸ¡ç·é¡
ä¿ææ ªåŒæ°
æ¥çš®
å ±åæ¥
ãŠã©ãããªã¹ã
5.34%
-1.30M
$822.83M
$822.83M
1.42M
åå°äœ & åå°äœè£œé è£
眮
2026-06-30
î
3.77%
+414.89K
$580.61M
$580.61M
10.02M
ãã€ãªãã¯ãããžãŒ & å»çç ç©¶
2026-06-30
î
3.41%
-767.03K
$525.07M
$525.07M
5.24M
éèãã¯ãããžãŒ(Fintech) & ã€ã³ãã©
2026-06-30
î
6
Crispr Therapeutics Ord Shs (US) (US)
H17182108
3.35%
-1.85M
$516.00M
--
9.46M
--
2026-06-30
î
3.08%
-21.73K
$474.52M
$474.52M
4.16M
ãœãããŠã§ã¢ & ITãµãŒãã¹
2026-06-30
î

